Russia registers world’s first nasal spray COVID-19 vaccine
Russia has become the first country to register a nasal spray form of the Sputnik V vaccine, developed by the Gamaleya Research Institute. The vaccine uses adenovirus vectors and induces mucosal and systemic immunity.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthRussia registers world’s first nasal spray COVID-19 vaccine
Sign in or subscribeBrowse free archive reportsRussia has become the first country to register a nasal spray form of the Sputnik V vaccine, developed by the Gamaleya Research Institute. The vaccine uses adenovirus vectors and induces mucosal and systemic immunity.